Associated Papers
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency).
McCarthy M et al.
Mayo Clinic Proceedings, 2026
ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.
Hou J et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2026
ELOC-Mutated Renal Cell Carcinoma is a Rare Indolent Tumor With Distinctive Genomic Characteristics.
Wang JJ et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2025
Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma.
Pei J et al.
Febs Open Bio, 2024
37964489 (PubMed )
Supplement: FEB4-14-112-s002.xlsx › AlphaFold_models
Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy.
Tian X et al.
Pathology Oncology Research : Por, 2021
34512202 (PubMed )
Supplement: Table1.XLSX › SNV_prediction
Extracting Complementary Insights from Molecular Phenotypes for Prioritization of Disease-Associated Mutations.
Wierbowski SD et al.
Current Opinion in Systems Biology, 2018
Integrated molecular analysis of clear-cell renal cell carcinoma.
Sato Y et al.
Nature Genetics, 2013
Select a paper to view details